Alpha Nuclide's Research & Manufacturing Capabilities to Unlock Access to China Market, Targeting Clinical Trials for NY-703 in HCC in 2026 "We are excited to partner with Alpha Nuclide, a leader in ...
Tokyo Electric Power Company Holdings (TEPCO) will begin its 16th release of treated radioactive water from the Fukushima ...